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In 2-stage revision knee surgery ending with a tumor pros-
thesis, the bone loss is so large that in the interim period the 
patient can be treated with (1) rest in bed with or without 
skeletal traction, (2) external fixation, or (3) a custom-made 
spacer. Apart from the technical challenge of eradicating these 
infections, the stabilization of the knee and preservation of leg 
length until reimplantation can be a problem. We present our 
early experience with a new type of knee spacer for patients 
with very large bone loss.
Surgical technique
A thigh tourniquet was used if possible. An anterior incision 
extending proximally was done, extending the old incision. 
After thorough debridement with removal of hardware, all 
infected and/or necrotic bone was resected. Remaining tibial 
and femoral canals were reamed and sized with pulse lavage 
irrigation before and after reaming. Retrograde femoral IM 
nails (AO) were inserted by press-fit in the full lengths of 
the femoral and tibial canals under fluoroscopic guidance. In 
the first 2 cases, 1 of the nails was locked; in the last 4 cases, 
no locking screws were used. Thereafter, the assistant pulled 
the leg into maximum possible length while the free ends of 
the nails were cemented together using 3–5 portions of bone 
cement as a spacer between the femur and tibia. In 4 cases, 
the nails inserted were so long that the free ends could be con-
nected with 1 or 2 screws through the locking holes before 
cementing. After cementing, all metal between the bony ends 
of the femur and tibia was covered with cement, but no cement 
was put into the canals. The spacer was thus made of 2 retro-
grade intramedullary nails, preferably connected with 1 or 2 
screws or wires, and the “free ends” of the nails were embed-
ded in cement (Refobacin Revision; Biomet) (Figures 1 and 2), 
which contained clindamicin and gentamicin. Amphotericin 
B was added in a patient with candida infection. The patients 
were mobilized with 2 crutches and toe-touch weight bearing. 
A softcast cylinder was optional during mobilization. 
Patients
Between 2006 and 2008, we operated 6 selected patients with 
this new spacer technique. 5 of the patients had an infected 
revision knee arthroplasty (Figure 1) and 1 had a posttrauma-
infected distal femoral pseudarthrosis (Figure 2). The mean 
number of previous operations was 7 (2–11) and mean age at 
the spacer operation was 63 (37–79) years. In all 6 patients 
femoral bone loss was extensive, ranging from supracondy-
larly to the middle of the femur, thus exceeding type III in 
the AORI classification (Engh and Ammeen 1998). The tibial 
bone loss was type II (2) or type III (4). In all patients, the 
extensor mechanism was intact, and despite open drainage in 
3 patients, no plastic surgery was needed. Four patients had 
been recommended amputation above the knee before referral.
The microbiology was mixed in 4 patients (4 Staphylocco-
cus epidermidis, 3 Enterococcus faecalis, 2 Staphyloccocus 
aureus, 1 Enterobacter cloacae, and 1 Escherichia coli), and 
single in 2 patients (1 Staphyloccocus epidermidis, 1 Candida 
parapsilosis). The first stage was followed by treatment with 
systemic antibiotics (with guidance from a clinical microbiol-
ogist) until clinical eradication, and normalized inflammatory 
markers. Then the second stage with implantation of a tumor 
prosthesis was done.
The mean period with IM spacer was 3 (1.5–6.5) months, 
and the leg length shortening was 3.5 (0–10) cm preoperatively 
and 2 (0–3.5) cm after insertion of the tumor prosthesis. Mean 
ROM was 27 (10–50) degrees preoperatively and 58 (35–105) 
degrees after stage 2.
1 spacer fractured after 1 week. The patient was reoperated, 
but the spacer fractured again and the knee was left with con-
siderable shortening in a plaster for 2.5 months before suc-
cessful implantation of a tumor prosthesis. This heavy male 
patient did not respect our advice not to bear full weight and 
for a period was considered a candidate for amputation. Apart 
from the patient with a fractured spacer, no reoperations were 312  Acta Orthopaedica 2012; 83 (3): 311–313
needed before reimplantation; 5 patients had a GMRS tumor 
prosthesis (Stryker) and 1 had a MEGA-C tumor prosthesis 
(Valdemar Link). 
2 patients died: 1 died 5 weeks postoperatively and 1 died 
5 years postoperatively. Both were free of infection and died 
because of cardiac disease. 4 patients are still alive (as of 
December 2011) and free of infection. 2 patients have been 
reoperated after reimplantation, both after about 1 year (1 
aseptic loosening of the femoral stem and 1 breakage of a 
femoral stem connection).
Discussion
We consider the present spacer technique to be safe, as all 
infections were cured. All hardware implanted during the first 
stage is usually covered with antibiotic-loaded cement, both in 
non-tumor cases (Antoci et al. 2009, Incavo et al. 2009, Rao et 
et al. 2009) and tumor cases (Grimer et al. 2002, Manoso eal. 
2006), so our technique is truly new and controversial. The 
fact that all infections were cured despite the use of uncoated 
IM nails can be attributed to aggressive debridement at stage 1 
with resection of all bone tissue that was not considered vital 
and free of infection, plus full cement coating of the nails in 
the primarily infected area. It is noteworthy that no further 
surgery for infection was needed after this first stage. 
The small amount of literature that is available does not 
favor 1-stage revisions in complex cases with substantial bone 
loss and frequent fistula/skin problems (Ramappa et al. 2010). 
The size of the bone loss in our patients did not permit the 
implantation of unconstrained or semi-constrained spacers, 
which have been described by others as being suited for large 
bone loss (Incavo et al. 2009, MacAvoy and Ries 2005), and 
perhaps the soft tissues even profited from the immobilization. 
Despite the large number of previous operations and a mean of 
3 months with a stiff knee, the movement achieved after stage 
2 was acceptable. 
The usual spacer technique in very large bone loss is inser-
tion of 1 antibiotic-covered rod (Grimer et al. 2002, Antoci et 
al. 2009, Rao et al. 2009) or a prosthesis (Sherman et al. 2008). 
Our IM spacer is probably even more mechanically stable and 
is technically easy, both to perform and—also important—to 
remove without further loss of bone during stage 2. It is also 
applicable in infected tumor cases, when tumor itself is not 
an issue. 
Figure 1. A 79-year-old woman with candida ostitis, who had the least 
bone loss on the femoral side, and the most bone loss on the tibial 
side. A. Status at referral with a cement spacer and the tibial stem still 
well-fixed to the bone. B. After revision, including removal of the tibial 
stem and insertion of an intramedullary spacer made by 2 retrograde 
nails connected with wires plus bone cement. C. X-ray after removal of 
the spacer and insertion of a tumor prosthesis (C).
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Figure 2. A 37-year-old man with an infected pseudartrosis. A. 
Preoperatively; pseudarthrosis of the distal femur. B. Spacer inserted 
after revision, with resection of all infected and dead bone. C. After 
stage 2 (one year postoperatively), with tumor prosthesis inserted. 
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Our method ensures preservation of leg length and makes 
ambulation and nursing between the 2 stages very easy com-
pared to the traditional 2–3 months of skeletal traction in bed. 
External fixation (Berend and Lombardi 2009) will also favor 
ambulation, but introduces an additional risk of infection and 
weakens the rest of the femur where the tumor prosthesis will 
be implanted. 
Our technique requires enough bone, on both the femoral 
and tibial side, to first insert an intramedullary nail in press-
fit, and secondly to implant a prosthetic stem. A remaining 
proximal femoral bony canal of less than about 15 cm prob-
ably excludes our technique, and skeletal traction in a bed 
and subsequent total femoral replacement will be the choice 
(Berend et al. 2004). Tibial bone loss of that size will prob-
ably lead to amputation, but a modular cemented nail (Rao 
et al. 2009)—or in rare cases a tumor prosthesis (Russell et 
al. 2008)—might be an alternative. Amputation is sometimes 
considered in patients with persistent periprosthetic or post-
traumatic infection of the knee despite several operations, and 
is indeed an effective operation regarding cure of infection. 
However, mobility decreases, and a tumor prosthesis actually 
gives good functional results (Berend and Lombardi 2010) 
and even seems to be cost effective compared to amputation 
(Grimer et al. 1997).
On the basis of our early experience, we recommend that 
the 2 nails be inserted in press-fit without the use of locking 
screws. The connection of the free ends of the nails can be 
reinforced with 1 or 2 screws before applying cement, but can 
also be connected with wires. The trick is to secure the leg 
length before cementing. 
In conclusion, the present intramedullary knee spacer 
appears to be an effective, safe, and patient-friendly method at 
the first stage of 2-stage revisions, where bone loss is so large 
that a tumor prosthesis will be needed at stage 2. 
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